Tag: Burrill

Burrill & Co releases Biotech 2012: Innovating in the New Austerity

In California, Burrill & Co released Biotech 2012, and in this year’s annual review focused intensively on “Innovating in the New Austerity.” The massive book provides analysis of the life sciences industry with data, graphs, and industry highlights including new product approvals, advances in technology, and details of financing and M&A transactions, and explains the […]

April 17, 2012 More

Cobalt raises $20M in Series D round; Parsons & Whittemore joins

In California, Cobalt Technologies announced that it has closed a $20M Series D funding round.  The round was led by The Whittemore Collection Ltd., the investment vehicle of Parsons & Whittemore, formerly one of the world’s largest manufacturers of market pulp and builder of some 60 pulp mills in 28 countries. All of Cobalt’s current […]

May 3, 2011 | 0 Comments More

Burrill LAM Life Sciences conference tackles agricultural biotechnology, industrial biotechnology and biofuels/bioenergy

In Brazil, the Burrill Latin American Life Sciences Conference will take place May 19-20 at the Copacabana Sofitel in Rio de Janeiro. The event will bring together CEOs, Scientists, Corporate executives, financiers, regulators, government officials and academic leaders from around the world to discuss with industry leaders in Latin America the state of the healthcare […]

April 4, 2011 | 0 Comments More

What do next-gen biofuel companies offer the biotech investor ?

By John Hamer, PhD, Managing Director, Burrill & Company It’s interesting that JMP Healthcare Research’s Lazy Man Morning Notes carried the news of the Amyris IPO.  Biotech investors will probably look seriously at this area, as much of the underlying technology (genomics, synthetic biology etc.) is shared with biotech and the first two companies’ out […]

September 29, 2010 | 0 Comments More